NOT-HL-23-125: Notice of Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards (RFA-HL-23-008 and RFA-HL-23-009)

Notice of Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards (RFA-HL-23-008 and RFA-HL-23-009)

Notice Number:

NOT-HL-23-125

Key Dates

Release Date:

December 18, 2023

Related Announcements

December 9, 2022 - Notice of Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards (RFA-HL-23-008 and RFA-HL-23-009). See Notice NOT-HL-22-062.
November 16, 2021 - NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional). See NOFO RFA-HL-23-008.
November 16, 2021 - NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional). See NOFO RFA-HL-23-009.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) will hold a pre-application technical assistance webinar regarding applications for the following RFAs:

RFA-HL-23-008: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

RFA-HL-23-009: NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

This pre-application webinar will take place on January 25, 2024 at 1:00 PM EST. The purpose of and requirements for both RFAs will be reviewed. Attendees will have the opportunity to ask questions. Program staff from the NHLBI and the National Center for Advancing Translational Sciences (NCATS) will be available to provide responses.

While not required, participation in the webinar is strongly encouraged. Potential applicants are strongly encouraged to submit questions prior to the webinars to NHLBI_SBIR@mail.nih.gov. Please indicate "Phase IIB Program Webinar" in the subject line of the email.

To register for the webinar, please visit https://nih.zoomgov.com/meeting/register/vJIsf-CtrzktErAr3BwGEUhtfCJaOyuZgCo

Inquiries

Please direct all inquiries to:

Jain Krotz, Ph.D.
Innovation and Commercialization Office
Division of Extramural Research Activities
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-435-7677
Email: jain.krotz@nih.gov